Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1987 1
1988 7
1989 7
1990 3
1991 1
1992 2
1993 1
1994 2
1998 3
1999 1
2000 1
2001 1
2002 1
2003 3
2004 4
2005 7
2006 4
2007 3
2009 4
2010 5
2011 5
2012 4
2013 6
2014 10
2015 9
2016 5
2017 13
2018 7
2019 15
2020 10
2021 16
2022 19
2023 22
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

197 results

Results by year

Filters applied: . Clear all
Page 1
Treating menopause - MHT and beyond.
Davis SR, Baber RJ. Davis SR, et al. Among authors: baber rj. Nat Rev Endocrinol. 2022 Aug;18(8):490-502. doi: 10.1038/s41574-022-00685-4. Epub 2022 May 27. Nat Rev Endocrinol. 2022. PMID: 35624141 Review.
Global Consensus Position Statement on the Use of Testosterone Therapy for Women.
Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L, Wierman ME. Davis SR, et al. Among authors: baber r. J Clin Endocrinol Metab. 2019 Oct 1;104(10):4660-4666. doi: 10.1210/jc.2019-01603. J Clin Endocrinol Metab. 2019. PMID: 31498871 Free PMC article.
World Menopause Day.
Baber R. Baber R. Climacteric. 2023 Oct;26(5):409-410. doi: 10.1080/13697137.2023.2247269. Climacteric. 2023. PMID: 37671974 No abstract available.
Marketing the menopause.
Baber R. Baber R. Climacteric. 2023 Jun;26(3):171-172. doi: 10.1080/13697137.2023.2196885. Climacteric. 2023. PMID: 37150194 No abstract available.
Quo vadis?
Baber R. Baber R. Climacteric. 2022 Dec;25(6):531-532. doi: 10.1080/13697137.2022.2134610. Climacteric. 2022. PMID: 36343926 No abstract available.
Reflections.
Baber R. Baber R. Climacteric. 2021 Dec;24(6):527-528. doi: 10.1080/13697137.2021.1985308. Climacteric. 2021. PMID: 34747671 No abstract available.
Reversal of the renal hyperglycemic memory in diabetic kidney disease by targeting sustained tubular p21 expression.
Al-Dabet MM, Shahzad K, Elwakiel A, Sulaj A, Kopf S, Bock F, Gadi I, Zimmermann S, Rana R, Krishnan S, Gupta D, Manoharan J, Fatima S, Nazir S, Schwab C, Baber R, Scholz M, Geffers R, Mertens PR, Nawroth PP, Griffin JH, Keller M, Dockendorff C, Kohli S, Isermann B. Al-Dabet MM, et al. Among authors: baber r. Nat Commun. 2022 Aug 27;13(1):5062. doi: 10.1038/s41467-022-32477-9. Nat Commun. 2022. PMID: 36030260 Free PMC article.
Peer review: improving feedback.
Baber R. Baber R. Climacteric. 2023 Feb;26(1):1-2. doi: 10.1080/13697137.2022.2152598. Climacteric. 2023. PMID: 36637089 No abstract available.
Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG.
Hadji P, Aapro MS, Body JJ, Gnant M, Brandi ML, Reginster JY, Zillikens MC, Glüer CC, de Villiers T, Baber R, Roodman GD, Cooper C, Langdahl B, Palacios S, Kanis J, Al-Daghri N, Nogues X, Eriksen EF, Kurth A, Rizzoli R, Coleman RE. Hadji P, et al. Among authors: baber r. J Bone Oncol. 2017 Mar 23;7:1-12. doi: 10.1016/j.jbo.2017.03.001. eCollection 2017 Jun. J Bone Oncol. 2017. PMID: 28413771 Free PMC article. Review.
197 results